IP Library Granted Patent US 10,150,952
Granted Patent B2
US 10,150,952 · App. 15/540,690 · Granted Dec 11, 2018

Compositions and methods for protein glycosylation

Inventors: Jurgen Haas (Basel, CH); Julian Ihssen (Dübendorf, CH); Michael Thomas Kowarik (Schlieren, CH); Torsten Franz Schwede (Basel, CH); Linda Christiane Thöny-Meyer (Dübendorf, CH)
Assignee: GLAXOSMITHKLINE BIOLOGICALS S.A.
C12N9/1081C12P21/005
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,150,952
App. No.
15/540,690
Granted
Dec 11, 2018
Kind
B2
Abstract

Described herein are oligosaccharyl transferases for use in N-glycosylating proteins of interest in vitro and in host cells. Methods for using such oligosaccharyl transferases, nucleic acids encoding such oligosaccharyl transferases, and host cells comprising such oligosaccharyl transferases are also provided herein. Glycoconjugates generated by using such oligosaccharyl transferases are also provided herein.

Claims (14)

1. An N-oligosaccharyl transferase comprising an amino acid sequence having at least 95% identity to SEQ ID NO:1, wherein the N-oligosaccharyl transferase can detectably link an oligosaccharide or polysaccharide lacking an N-acetyl sugar at the reducing end to a carrier protein at the N-glycosylation consensus sequence and wherein the N-oligosaccharyl transferase comprises one or more substitutions at positions corresponding to positions in the polypeptide of SEQ ID NO: 1 selected from the group consisting of 77, 80, 196, 311, 462, 482, 483, and 477.

2. The N-oligosaccharyl transferase of claim 1 , wherein said N-oligosaccharyl transferase comprises two or more substitutions at positions corresponding to positions in the polypeptide of SEQ ID NO: 1 selected from the group consisting of 77, 80, 196, 311, 462, 482, 483, and 477.

3. The N-oligosaccharyl transferase of claim 1 , wherein said N-oligosaccharyl transferase comprises a substitution at a position corresponding to position 311 of the polypeptide of SEQ ID NO: 1.

4. The N-oligosaccharyl transferase of claim 1 , wherein said N-oligosaccharyl transferase further comprises one or more substitutions at positions corresponding to positions in the polypeptide of SEQ ID NO: 1 selected from the group consisting of positions 287, 288, 289, 290, 291, 292, 293, and 294.

5. The N-oligosaccharyl transferase of claim 4 , wherein said N-oligosaccharyl transferase comprises one or more substitutions at positions corresponding to positions in the polypeptide of SEQ ID NO: 1 selected from the group consisting of positions 287, 288, 289, and 294.

6. A nucleic acid encoding an N-oligosaccharyl transferase comprising an amino acid sequence having at least 95% identity to SEQ ID NO:1, wherein the N-oligosaccharyl transferase can detectably link an oligosaccharide or polysaccharide lacking an N-acetyl sugar at the reducing end to a carrier protein at the N-glycosylation consensus sequence and wherein the N-oligosaccharyl transferase comprises one or more substitutions at positions corresponding to positions in the polypeptide of SEQ ID NO: 1 selected from the group consisting of 77, 80, 196, 311, 462, 482, 483, and 477.

7. A host cell comprising the N-oligosaccharyl transferase of claim 1 .

8. A method of producing a bioconjugate comprising culturing the host cell of claim 7 in a cell culture medium, and purifying the bioconjugate from the host cell culture.

9. An N-oligosaccharyl transferase comprising an amino acid sequence having at least 95% identity to SEQ ID NO: 2, wherein the N-oligosaccharyl transferase can detectably link an oligosaccharide or polysaccharide lacking an N-acetyl sugar at the reducing end to a carrier protein at the N-glycosylation consensus sequence and wherein the N-oligosaccharyl transferase comprises one or more substitutions at positions corresponding to positions in the polypeptide of SEQ ID NO: 2 selected from the group consisting of 79, 82, 314, 488, and 489.

10. The N-oligosaccharyl transferase of claim 9 , wherein said N-oligosaccharyl transferase comprises two or more substitutions at positions corresponding to positions in the polypeptide of SEQ ID NO: 2 selected from the group consisting of 79, 82, 314, 488 and 489.

11. The N-oligosaccharyl transferase of claim 9 , wherein said N-oligosaccharyl transferase comprises a substitution at a position corresponding to position 314 of the polypeptide of SEQ ID NO: 2.

12. A nucleic acid encoding an N-oligosaccharyl transferase comprising an amino acid sequence having at least 95% identity to SEQ ID NO:2, wherein the N-oligosaccharyl transferase can detectably link an oligosaccharide or polysaccharide lacking an N-acetyl sugar at the reducing end to a carrier protein at the N-glycosylation consensus sequence and wherein the N-oligosaccharyl transferase comprises one or more substitutions at positions corresponding to positions in the polypeptide of SEQ ID NO: 2 selected from the group consisting of 79, 82, 314, 488, and 489.

13. A host cell comprising the N-oligosaccharyl transferase of claim 9 .

14. A method of producing a bioconjugate comprising culturing the host cell of claim 13 in a cell culture medium, and purifying the bioconjugate from the host cell culture.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 29, 2017
From: GLYCOVAXYN AG
To: GLAXOSMITHKLINE BIOLOGICALS SA
Reel/Frame 042866/0349 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 29, 2017
From: KOWARIK, MICHAEL THOMAS; IHSSEN, JULIAN; THÖNY-MEYER, LINDA CHRISTIANE; HASS, JURGEN; SCHWEDE, TORSTEN FRANZE
To: GLYCOVAXYN AG
Reel/Frame 042866/0391 →
Continuity (3)
Provisional Application 62098071 · Dec 30, 2014
Provisional Application 62097975 · Dec 30, 2014
Related Publication 20180002679A1 · Jan 4, 2018
Cited By (4)
US 12,214,029 US 12,233,118 US 12,233,121 US 12,274,742